452 related articles for article (PubMed ID: 25889090)
1. Assessment into the usage of levetiracetam in a canine epilepsy clinic.
Packer RM; Nye G; Porter SE; Volk HA
BMC Vet Res; 2015 Feb; 11():25. PubMed ID: 25889090
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial.
Muñana KR; Thomas WB; Inzana KD; Nettifee-Osborne JA; McLucas KJ; Olby NJ; Mariani CJ; Early PJ
J Vet Intern Med; 2012; 26(2):341-8. PubMed ID: 22295869
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs.
Volk HA; Matiasek LA; Luján Feliu-Pascual A; Platt SR; Chandler KE
Vet J; 2008 Jun; 176(3):310-9. PubMed ID: 17468024
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam monotherapy for treatment of structural epilepsy in dogs: 19 cases (2010-2015).
Kelly D; Raimondi F; Shihab N
Vet Rec; 2017 Oct; 181(15):401. PubMed ID: 28847876
[TBL] [Abstract][Full Text] [Related]
5. A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy.
Fredsø N; Sabers A; Toft N; Møller A; Berendt M
Vet J; 2016 Feb; 208():44-9. PubMed ID: 26639829
[TBL] [Abstract][Full Text] [Related]
6. Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.
Hardy BT; Patterson EE; Cloyd JM; Hardy RM; Leppik IE
J Vet Intern Med; 2012; 26(2):334-40. PubMed ID: 22295898
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy.
Muñana KR; Nettifee-Osborne JA; Papich MG
J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
Perry MS; Benatar M
Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
[TBL] [Abstract][Full Text] [Related]
9. Randomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure types.
Fang Y; Wu X; Xu L; Tang X; Wang J; Zhu G; Hong Z
J Clin Neurosci; 2014 Jan; 21(1):55-62. PubMed ID: 24231559
[TBL] [Abstract][Full Text] [Related]
10. Long-term levetiracetam treatment of epilepsy patients: clinical audit.
Kuba R; Novotná I; Brázdil M; Kocvarová J; Tyrliková I; Mastík J; Rektor I
Epilepsy Res; 2006 Dec; 72(2-3):111-9. PubMed ID: 16930945
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness and tolerability of levetiracetam in 43 children and adolescents with epilepsy].
Herranz JL; Rufo-Campos M; Arteaga R
Rev Neurol; 2003 Dec 1-15; 37(11):1005-8. PubMed ID: 14669138
[TBL] [Abstract][Full Text] [Related]
13. A prospective observational longitudinal study of new-onset seizures and newly diagnosed epilepsy in dogs.
Fredsø N; Toft N; Sabers A; Berendt M
BMC Vet Res; 2017 Feb; 13(1):54. PubMed ID: 28209153
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam monotherapy--outcomes from an epilepsy clinic.
Stephen LJ; Kelly K; Parker P; Brodie MJ
Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy.
Ben-Menachem E; Gilland E
Seizure; 2003 Apr; 12(3):131-5. PubMed ID: 12651076
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of rectal levetiracetam as add-on treatment in dogs affected by cluster seizures or status epilepticus.
Cagnotti G; Odore R; Gardini G; Amedeo S; Bertone I; Guerriero G; Lentini L; Dappiano E; D'Angelo A
BMC Vet Res; 2018 Jun; 14(1):189. PubMed ID: 29914474
[TBL] [Abstract][Full Text] [Related]
17. Incidence of postoperative seizures with and without levetiracetam pretreatment in dogs undergoing portosystemic shunt attenuation.
Fryer KJ; Levine JM; Peycke LE; Thompson JA; Cohen ND
J Vet Intern Med; 2011; 25(6):1379-84. PubMed ID: 22092631
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic epilepsy in dogs: owners' perspectives on management with phenobarbitone and/or potassium bromide.
Chang Y; Mellor DJ; Anderson TJ
J Small Anim Pract; 2006 Oct; 47(10):574-81. PubMed ID: 17004949
[TBL] [Abstract][Full Text] [Related]
19. Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis.
Hirsch M; Hintz M; Specht A; Schulze-Bonhage A
Seizure; 2018 Oct; 61():98-103. PubMed ID: 30118932
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of levetiracetam (keppra) add-on treatment in adult patients with refractory epilepsy in two tertiary centers].
Auriel E; Chistik V; Blatt I; Margolin N; Neufeld M
Harefuah; 2007 Apr; 146(4):269-71, 318. PubMed ID: 17476932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
